Volume : 11, Issue : 07, July – 2024

Title:

BIOLOGICAL ACTIVITIES OF BENZIMIDAZOLE DERIVATIVES – A REVIEW

Authors :

Purna Nagasree Kurre*, Krishnaveni Patnala, Thalla Srinu, Gunturi Surya Varchas Varma , Jagadeesh Panda

Abstract :

Over the last few decades, data on the production of benzimidazole and its derivatives, as well as an assessment of their biological activity, have been reviewed. The synthesis and development of novel compounds are discussed historically, since they are considered a significant heterocyclic moiety with a broad variety of medicinal uses. The synthesis of benzimidazoles and their derivatives continues to be a primary focus for synthetic chemistry communities due to their wide range of activities, which include anti-bacterial, anti-viral, anti-fungal, anti-diabetic, anti-helminthic, anti-convulsant, anti-HIVs, anti-hypertensive, anti-cancer, anti-inflammatory, and anti-oxidant. The goal of this study is to provide up-to-date information on the biological activities and synthesis of various benzimidazole derivatives. Additionally, we have attempted to provide an overview of the chemistry involved in the production of several benzimidazole derivatives for use in medicine.
Keywords: Benzimidazole, biological activity, synthesis.

Cite This Article:

Please cite this article in press Purna Nagasree Kurre et al., Biological Activities Of Benzimidazole Derivatives – A Review.,Indo Am. J. P. Sci, 2024; 11 (07).

Number of Downloads : 10

References:

1. Singh N, Pandurangan A, Rana K, Anand P, Ahamad A, Tiwari A K, Benzimidazole: A short review of their antimicrobial activities, International current pharmaceutical journal, vol1, issue5/05, 1(5)119-127,2012.
2. Anand K, Wakode S, Synthesis, characterization and biological evaluation of benzimidazole derivatives, international journal of pharmaceutical sciences and research, volume 9, issue 2, 617-624, 2018.
3. Faheem M, Ratharu A, Pandey A, Singh V K, Tiwari A K, a review on the modern synthetic approach of benzimidazole candidate, Chemistry select, vol 5(13), 3981-3994, 2020.
4. Wright JB, The chemistry of benzimidazole, Internationl journal of organic chemistry, vol 48(3), 397-541, june 1951.
5. Kaushik P, Singh R B, Kumar R, Various approaches for the synthesis of benzimidazole derivatives and their catalytic application for organic transformation, Applied chemical engineering, vol 6, issue1, 8178-1, 2003.
6. Srivasthava V, Srivasthava AM, Tiwari AK, Srivasthava R, Sharma R, Sharma H, Singh VK, Disubstituted 4 (3H) quinazolones: a novel class of antitumor agents, chemical biology and drug design, vol 74 (3), 297-301, 2009.
7. Kubo K, kohara Y, Yoshimura Y, Inada Y, Shibouta Y, Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids, Journal of medicinal chemistry, vol 36(16), 2343-2349, 1993.
8. Shrivastava N, Naim MJ, Alam MD, Nawaz F, Ahmed S, Alam O, Benzimidazole as scaffold as anticancer agents: synthetic approach and structure-activity relationship, Archiv der Pharmazie-Chemistry in Life sciences, vol 350(160), 2017.
9. Dhanalakshmi P, Thimimarayaperumal S, Shanmugam S, Metal catalyst free one-pot synthesis of 2-arylbenzimidazoles from alpha-aroylketene dithioacetals, Royal society of chemistry’s journal Advances, vol4, 12028-12036, 2014.
10. Singh SP, Parmar SS, Pandey BR, Synthesis of 2-substituted benzylidene-6-b-nitrothiazolo[3,2-alpha] benzimidaol-3(2H) ones as possible anticonvulsants, international journal of medicinal chemistry, vol 14, issue 6, 1093-1095.
11. Srinivasulu R, kumar KRR, Satyanarayana PVV, Facile and effective method for synthesis of benzimidazole derivatives catalyzed by zinc triflate, Green and sustainable chemistry, vol 4, 33-37,2014.
12. Gutierrez CED, Vasquez C, Hernandez ET, Huerta M, Nitazoxanide compared with quinafamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children, The American journal of tropical medicine and hygiene, vol 66(3), 251-254, 2002.
13. Prajapat, kumawat PM, Talesara GL, Kalal P, Agarwal S, Kapoor CS, Benzimidazole as a versatile biophore in drug discovery: a review, Chemical Biology Interfaces, vol 8(1), 1-10,2018.
14. Hashem HE, Bakri YE, An over view on novel synthesis approaches and medicinal applications of benzimidazole compounds. Arabian journal of chemistry, vol 14(11),103418, 2021.
15. Rithe SR, Jagtap RS, Ubarhande SS, One pot synthesis of substituted benzimidazole derivatives and their characterization, Rasayan journal of chemistry, 8(2), 213-217, 2015.
16. Chari MA, Zaied-a-mosaa, Shobha D, Malayalama S, Synthesis of multifunctional 2- substituted benzimidazoles copper (II) hydroxides efficient solid catalyst, international journal of organic chemistry, vol 3(4), 243-250, 2013.
17. Mamedov VA, Zhukova NA, Gubaidullin AT, one spot synthesis of 7-(benzimidazole-2-yl) thioxolumazine and –lumazine derivatives via h2so4 catalyzed rearrangement of quinoxalinones when exposed to 5,6-diamino-2-mercapto-and 2,5,6-triaminopyrimidine-4-ols, The journal of organic chemistry, vol 88(24), 14942-14953, 2018.
18. Ismail MA, Brun R, Wenzler T, Tanious FA, Wilson WD, Boykin DW, Dicationic biphenyl benzimidazole derivatives as antiprotozoal agents, Bioorganic& medicinal chemistry, vol 12, 5405-5413, 2004.
19. Andrzejewska M, Yepez-mulia L, Tapia A, Cedilla-Rivera R, Laudy AE, Starosciak BJ, Kazimierczuk Z, Synthesis of antiprotozoal and antibacterial activities of S-substituted 4,6-dibromo-and 4,6-dichloro-2mercaptobenzimidazoles, European journal of pharmaceutical sciences, vol 21,323-329, 2004.
20. Mavrova AT, Anichina KK, Vuchev DI, Issenov JA, Denkova PS, Kondeva MS, Micheva MK, Anthelminthic activity of some newly synthesized 5(6)- (un)substituted -1H-benzimidazol-2-ylthioacetylpiperazine derivatives, European journal of medicinal chemistry, vol 41,1412-1420, 2006.
21. Munguia B, Mendina P, Espinosa R, Lanz A, Saldana J, Andina M.J, Ures X, Lopez A, Manta E, Dominguez L, Synthesis and anthelminthic evaluation of novel valerolactum-benzimidazole hybrids, lett. Drug design discovery, vol 10(10), 1007-1014, 2013.
22. Yun he, Baogen Wu, Jun yang, Dale robinson, 2-piperidin-4-yl-benzimidazoles with broad spectrum antibacterial activities, Biooraganic & medicinal chemistry, 13(19)0-3253-6, 2003.
23. Kumar BVS, Vidya SD, Kumar RV, Bhirud SB, Mane RB, Synthesis and antibacterial activity of some novel 2-(6-flurochroman-2-yl)-1-alkyl/acyl/aroyl-1H-benzimidazoles, European journal of medicinal chemistry, vol 41,599-604, 2006.
24. Middleton T, Lim HB, Montgomery D, Rockeay T, Tang H, Cheng X, Lu L, kohl Brenner WE, Molla A, Kati WM, Inhibition of human immunodeficiency virus type I integrase by napthamidines and 2-aminobenzimidazoles, antiviral research, vol 64,35-45, 2004.
25. Goker H, Kus C, Boykin D, Yildiz S, Altanlar N, Synthesis of some new 2-substituted-phenyl-1H-benzimidazole-5-caronitriles and their potent activity against candida species, Bioorganic& medicinal chemistry, vol 10,2589-2596, 2002.
26. Kawasaki K, Masubachi M, Morikami K, Sogebe S, Aoyama T, Ebiike H, Niizuma S, Hayase M, Fujii T, Sakata K, Shindoh H, Shiratori Y, Aoki Y, Ohtsuka T, Shimma N, Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyl transferase, Bioorganic &Medicinal Chemistry, vol 13,87–91, 2003.
27. Ramla MM, Omar MA, Tokuda H, El-Diwani HI, Synthesis and inhibitory activity of new benzimidazole derivatives against Burkitt’s lymphoma promotion, Bioorganic& Medicinal Chemistry, vol15,6489–6496, 2007.
28. Zheng Y, Zheng M, Ling X, Liu Y, Xue Y, An L, Gu N, Jin M, Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A/B kinase inhibitors, Bioorganic& Medicinal Chemistry, vol 23,3523-3530,2013.
29. Minoura H, Takeshita S, Ita M, Hirosumi J, Mabuchi M, Kawamura I, Nakajima S, Nakayama O, Kayakiri H, Oku T, Ohkubo-Suzuki A, Fukagawa M, Kojo H, Hanioka K, Yamasaki N, Imoto T, /Kobayashi Y, Mutoh S, Pharmacological characteristics of a novel non thiazolidinedione insulin sensitizer, FK614, European Journal of Pharmacology, vol 494, 273–281, 2004.
30. Arora R.K, Kaur N, Bansal Y, Bansalm G, Novel coumarin benzimidazole derivatives as antioxidants and safer anti-inflammatory agents, Acta Pharmaceutica Sinica B, vol 4(5), 368-375,2014.
31. Mader M, Dios A, Shih C, Bonjouklian R, Li T, White W, Uralde BL, Sanchez-Martinez C, Prado M, Jaramillo C, Diego E, Cabrejas LMM, Dominguez C, Montero C, Shepherd T, Dally R, Toth JE, Chatterjee A, Pleite S, Blanco-Urgoiti J, Perez L, Barberis M, Lorite MJ, Jambrina E, Nevill CR, Lee PA, Schultz RC, Wolos JA, Li LC, Campbell RM, Anderson BD, Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as potent p38a MAP kinase inhibitors with excellent in vivo anti-inflammatory properties, Bioorganic& Medicinal Chemistry, vol 18,179–183,2008.
32. Cheng J, Xie J, Luo X, Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives, Bioorganic and Medicinal Chemistry, vol 15, 267-269,2005.
33. Clerq ED, Naesens L, In search of effective anti-HHV-6 agents, Journal of clinical virology, vol1, S82–S86,2006.
34. Zhang H.Z, Damu G.L.V, Cai G.X, Zhou C.H, Design, synthesis and antimicrobial evaluation of novel benzimidazole type of Fluconazole analogues and their synergistic effects with Chloromycin, Norfloxacin and Fluconazole, European Journal of Medicinal Chemistry, vol 64, 329-344, 2013.
35. Ansari K.F, Lal C, Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives, European Journal of Medicinal Chemistry, vol 44, 4028-4033, 2009.
36. Kalai T, Balog M, Szabo A, Gulyas G, Jeko J, Sumegi B, Hideg K, New poly (ADP-ribose) polymerase-1 inhibitors with antioxidant activity based on 4-carboxamidobenzimidazole-2-ylpyrroline and tetra hydropyridine nitroxides and their precursors, Journal of Medicinal chemistry, vol 52(6), 1619-1629, 2009.